TrialBMC gastroenterology2021

Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn's disease: a Chinese real-world study.

Jia-Yin Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.